Table 3.
Odds of pancreatic cancer by quintile of plasma markers and time between blood collection and diagnosis*
Years between plasma collection and cancer diagnosis† | No. of cases/controls | OR (95% CI) for quintile of plasma marker‡ | P trend§ | ||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |||
Insulin | |||||||
≥2 y | 405/889 | 1.0 | 1.13 (0.75 to 1.69) | 1.20 (0.79 to 1.82) | 1.51 (1.00 to 2.28) | 2.00 (1.32 to 3.00) | <.001 |
≥5 y | 296/655 | 1.0 | 1.15 (0.72 to 1.85) | 1.13 (0.69 to 1.83) | 1.24 (0.75 to 2.03) | 1.93 (1.19 to 3.15) | .003 |
≥10 y | 129/295 | 1.0 | 1.33 (0.62 to 2.85) | 1.41 (0.65 to 3.06) | 2.51 (1.19 to 5.30) | 2.77 (1.28 to 5.99) | .004 |
Proinsulin | |||||||
≥2 y | 406/890 | 1.0 | 1.21 (0.80 to 1.83) | 1.24 (0.81 to 1.89) | 1.36 (0.88 to 2.08) | 2.28 (1.49 to 3.48) | <.001 |
≥5 y | 296/656 | 1.0 | 1.16 (0.72 to 1.89) | 1.16 (0.71 to 1.89) | 1.02 (0.61 to 1.71) | 2.29 (1.41 to 3.72) | <.001 |
≥10 y | 130/298 | 1.0 | 1.50 (0.70 to 3.19) | 1.54 (0.72 to 3.30) | 1.26 (0.55 to 2.88) | 3.60 (1.68 to 7.72) | <.001 |
* CI = confidence interval; HPFS = Health Professionals Follow-up Study; NHS = Nurses’ Health Study; OR = odds ratio; PHS = Physicians’ Health Study; WHI = Women’s Health Initiative; WHS = Women’s Health Study.
† For the pancreatic cancer cases in the ≥2 years, ≥5 years, and ≥10 years groups, the median time between blood collection and pancreatic cancer diagnosis was 7.6 years, 9.3 years, and 13.5 years, respectively.
‡ Adjusted for prospective cohort (HPFS, NHS, PHS, WHI, WHS; which also adjusted for sex), smoking status (never, past, current <25 cigarettes/day, current ≥25 cigarettes/day, missing), fasting time (<4, 4–8, 8–12, ≥12 hours, missing) age at blood collection (continuous), race (white, black, other, missing) and body mass index (<18.5, 18.5–24.9, 25–29.9, ≥30kg/m2).
§ Test for trend calculated by entering quintile-specific median values for plasma marker as a continuous variable in logistic regression models. All P values were two-sided.